Initial experience of the safety and tolerability of the BNT162b2 (Pfizer-Bio-N-Tech) vaccine in extremely vulnerable children aged 12-15 years.
Hayley KingSanjay DeshpandeTamsin WoodbridgeTom HilliardJon StandingMary LewisLesley WardAdam FinnMarion Ruth RoderickPublished in: Archives of disease in childhood (2021)
Keyphrases